SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hatem A. El-mezayen, Hossam Darwish, Development of a novel score for early detection of hepatocellular carcinoma among high-risk hepatitis C virus patients, Tumor Biology, 2014, 35, 7, 6501

    CrossRef

  2. 2
    Xiao-Fei Liu, Zhi-De Hu, Xiao-Cui Liu, Yuan Cao, Chun-Mei Ding, Cheng-Jin Hu, Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma: A systematic review and meta-analysis, Clinical Biochemistry, 2014, 47, 3, 196

    CrossRef

  3. 3
    Takamasa Ohki, Ryosuke Tateishi, Masaaki Akahane, Shintaro Mikami, Masaya Sato, Koji Uchino, Toru Arano, Kenichiro Enooku, Yuji Kondo, Noriyo Yamashiki, Tadashi Goto, Shuichiro Shiina, Haruhiko Yoshida, Yutaka Matsuyama, Masao Omata, Kuni Ohtomo, Kazuhiko Koike, CT With Hepatic Arterioportography as a Pretreatment Examination for Hepatocellular Carcinoma Patients: A Randomized Controlled Trial, The American Journal of Gastroenterology, 2013, 108, 8, 1305

    CrossRef

  4. 4
    Takamasa Ohki, Ryosuke Tateishi, Masaaki Akahane, Shuichiro Shiina, Noriyo Yamashiki, Shintaro Mikami, Kenichiro Enooku, Eriko Goto, Ryota Masuzaki, Yuji Kondo, Tadashi Goto, Shinichi Inoo, Kuni Ohtomo, Masao Omata, Haruhiko Yoshida, Kazuhiko Koike, Characteristics of hepatocellular carcinoma nodules newly detected by computed tomography during arteriography and arterial portography: preliminary report of a randomized controlled trial, Hepatology International, 2012, 6, 3, 639

    CrossRef

  5. 5
    Sang-Jae Park, Chris E. Freise, Ryutaro Hirose, Robert K. Kerlan, Francis Y. Yao, John P. Roberts, Parsia A. Vagefi, Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma, Clinical Transplantation, 2012, 26, 4
  6. 6
    Carly Lodewyks, Jose F. Rodriguez, Jing Yan, Betty Lerner, DongFeng Sun, Julia D. Rempel, Julia Uhanova, Meaghan Labine, Gerald Y. Minuk, Activation of β-adrenergic receptors increases the in vitro migration of malignant hepatocytes, Hepatology Research, 2011, 41, 10
  7. You have free access to this content7
    Masatoshi Kudo, The 2008 Okuda lecture: Management of hepatocellular carcinoma: From surveillance to molecular targeted therapy, Journal of Gastroenterology and Hepatology, 2010, 25, 3
  8. 8
    Jiang Jingting, Wu Changping, Xu Ning, Zhu yibei, Wu Jun, Ji Mei, Xu Bin, Nilsson-Ehle Peter, Zhang Xueguan, Clinical evaluation of serum alpha-fetoprotein–IgM immune complexes on the diagnosis of primary hepatocellular carcinoma, Journal of Clinical Laboratory Analysis, 2009, 23, 4
  9. 9
    Indra Bachtiar, Julian Mulya Santoso, Benny Atmanegara, Rino Alvani Gani, Irsan Hasan, Laurentius Adrianto Lesmana, Ali Sulaiman, Jianren Gu, Susan Tai, Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma, Clinica Chimica Acta, 2009, 399, 1-2, 97

    CrossRef

  10. 10
    H.C. Spangenberg, O. Drognitz, R. Thimme, U. Hopt, Das hepatozelluläre Karzinom aus der Sicht des Internisten und des Chirurgen, Der Gastroenterologe, 2009, 4, 4, 301

    CrossRef

  11. 11
    David R. Nelson, Gary L. Davis, Ira Jacobson, Gregory T. Everson, Michael W. Fried, Stephen A. Harrison, Tarek Hassanein, Donald M. Jensen, Karen L. Lindsay, Norah Terrault, Nizar Zein, Hepatitis C Virus: A Critical Appraisal of Approaches to Therapy, Clinical Gastroenterology and Hepatology, 2009, 7, 4, 397

    CrossRef

  12. 12
    Hans Christian Spangenberg, Robert Thimme, Hubert E. Blum, Targeted therapy for hepatocellular carcinoma, Nature Reviews Gastroenterology & Hepatology, 2009, 6, 7, 423

    CrossRef

  13. 13
    Hans Christian Spangenberg, Robert Thimme, Hubert E Blum, Advances in prevention and diagnosis of hepatocellular carcinoma, Expert Review of Gastroenterology & Hepatology, 2008, 2, 3, 425

    CrossRef

  14. 14
    Detlef Schuppan, Nezam H Afdhal, Liver cirrhosis, The Lancet, 2008, 371, 9615, 838

    CrossRef

  15. 15
    Mark A Feitelson, Marcia M Clayton, Helena MGPV Reis, Guoyi Wu, Eva Ping Lu, Pharmacotherapy of chronic viral hepatitis and hepatocellular carcinoma, Expert Opinion on Pharmacotherapy, 2008, 9, 13, 2233

    CrossRef

  16. 16
    Gianluigi Giannelli, Emilia Fransvea, Paolo Trerotoli, Michel Beaugrand, Felice Marinosci, Luigi Lupo, Gisele Nkontchou, Pietro Dentico, Salvatore Antonaci, Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients, Clinica Chimica Acta, 2007, 383, 1-2, 147

    CrossRef

  17. 17
    Ting-Tsung Chang, Robert G. Gish, Robert de Man, Adrian Gadano, José Sollano, You-Chen Chao, Anna S. Lok, Kwang-Hyub Han, Zachary Goodman, Jin Zhu, Anne Cross, Deborah DeHertogh, Richard Wilber, Richard Colonno, David Apelian, A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B, New England Journal of Medicine, 2006, 354, 10, 1001

    CrossRef

  18. 18
    F. AZZAROLI, A. COLECCHI, F. LODATO, D. TRERÈ, M. L. BACCHI REGGIANI, D. FESTI, G. M. PRATI, E. ACCOGLI, S. CASANOVA, M. DERENZINI, E. RODA, G. MAZZELLA, A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis, Alimentary Pharmacology & Therapeutics, 2006, 24, 1
  19. 19
    Keri A. Sims, Abigail M. Woodland, Entecavir: A New Nucleoside Analog for the Treatment of Chronic Hepatitis B Infection, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006, 26, 12
  20. 20
    Tim F. Greten, Michael P. Manns, Firouzeh Korangy, Immunotherapy of hepatocellular carcinoma, Journal of Hepatology, 2006, 45, 6, 868

    CrossRef

  21. 21
    Smruti R Mohanty, Sonia S Kupfer, Vijay Khiani, Treatment of chronic hepatitis B, Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3, 8, 446

    CrossRef

  22. 22
    Anastasia Rivkin, A review of entecavir in the treatment of chronic hepatitis B infection, Current Medical Research and Opinion, 2005, 21, 11, 1845

    CrossRef

  23. 23
    Masatoshi KUDO, Staging system for hepatocellular carcinoma-it concept and clinical impact-, Kanzo, 2005, 46, 2, 53

    CrossRef